[ad_1] CHICAGO – Dapagliflozin (Farxiga / Forxiga, AstraZeneca) showed a nonsignificant trend in reducing the rate of major cardiac events (MACE), but a significant reduction in the number of hospitalizations for heart …
Read More »Dapagliflozin Reduces Diabetes Heart Failure
